NVRO — Nevro Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapTurnaround

Annual balance sheet for Nevro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	588	362	374	323	293
Net Total Accounts Receivable
Net Total Receivables	77.7	70.5	78.9	79.4	71.9
Total Inventory
Prepaid Expenses
Total Current Assets	753	531	563	531	476
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.7	38.2	35.7	33.5	47.7
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	789	575	602	636	554
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	239	82.2	79.2	83.4	103
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	401	271	279	343	323
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	388	304	324	293	231
Total Liabilities & Shareholders' Equity	789	575	602	636	554
Total Common Shares Outstanding